Letter to the Editor in reply to Dayyani and Morgenstern’s comment on the article “Identifying risk in the use of tumor markers to improve patient safety”

Artikel in diesem Heft

1. Frontmatter
2. Editorial
3. Biomarkers, inflammation and cancer: where to go?
4. Review
5. Analysis, detection and quantitation of mixed cryoglobulins in HCV infection: brief review and case examples
6. Mini Reviews
7. Calcitonin measurement and immunoassay interference: a case report and literature review
8. Exosomal non-coding RNAs: a promising cancer biomarker
9. Opinion Paper
10. Towards a new paradigm in laboratory medicine: the five rights
11. EFLM Recommendation
12. Recommendation for the review of biological reference intervals in medical laboratories
13. IFCC Position Paper
14. Assuring the quality of interpretative comments in clinical chemistry
15. General Clinical Chemistry and Laboratory Medicine
16. The effect of centrifugation speed and time on pre-analytical platelet activation
17. An assessment of clinical laboratory performance for the determination of manganese in blood and urine
18. Evaluation of antiphospholipid antibody assays using latent class analysis to address the lack of a reference standard
19. Evaluation of the hypochromic erythrocyte and reticulocyte hemoglobin content provided by the Sysmex XE-5000 analyzer in diagnosis of iron deficiency erythropoiesis
20. Cancer Diagnosis
21. Identifying risk in the use of tumor markers to improve patient safety
22. Association between Echinococcus granulosus infection and cancer risk – a pilot study in Cyprus
23. Dynamic change of the systemic immune inflammation index predicts the prognosis of patients with hepatocellular carcinoma after curative resection
24. Aberrant methylation of tumour suppressor genes WT1, GATA5 and PAX5 in hepatocellular carcinoma
25. Cardiovascular Diseases
26. High homocysteine and low folate plasma concentrations are associated with cardiovascular events but not bleeding during warfarin treatment
27. Hemolysis and Coagulation
28. Hemolysis rates in blood samples: differences between blood collected by clinicians and nurses and the effect of phlebotomy training
29. Letters to the Editor
30. Harmonisation of the laboratory testing process: need for a coordinated approach
31. Pseudohyperkalemia due to severe leukocytosis: case presentation
32. When obtaining a blood sample from the right arm was not the right thing to do: a case of elevated parathyroid hormone levels 27 years after thyroidectomy
33. Raising awareness of assay compatibility with heparinized plasma
34. Improved protocol for extraction of genomic DNA from formalin-fixed paraffin-embedded tissue samples without the use of xylene
35. Effect of refrigeration, centrifugation, acidification, heat treatment and storage on urine calcium, magnesium and phosphate
36. Letter in response to: Identifying risk in the use of tumor markers to improve patient safety
37. Letter to the Editor in reply to Dayyani and Morgenstern’s comment on the article “Identifying risk in the use of tumor markers to improve patient safety”
38. Level of red cell distribution width is affected by various factors
39. Red blood cell distribution: an index without additional cost in estimating the prognosis of acute pancreatitis
40. Testing of total 25(OH)vitamin D: agreement and discrepant cases between Cobas^® 8000 and Liaison^® XL methods
41. Expression profiling and ontology analysis of circulating long non-coding RNAs in septic acute kidney injury patients